HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yuka Sasaki Selected Research

Conditioned Culture Media

7/2021A Combination of GM-CSF and Released Factors from Gamma-Irradiated Tumor Cells Enhances the Differentiation of Macrophages from Bone Marrow Cells and Their Antigen-Presenting Function and Polarization to Type 1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yuka Sasaki Research Topics

Disease

23Neoplasms (Cancer)
05/2022 - 05/2005
21Tuberculosis (Tuberculoses)
10/2020 - 08/2002
10Pulmonary Tuberculosis
10/2020 - 12/2003
9Infections
05/2022 - 07/2004
7Carcinogenesis
03/2021 - 05/2005
6Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
07/2019 - 08/2003
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2022 - 11/2016
4Disease Progression
01/2020 - 07/2008
3Lung Neoplasms (Lung Cancer)
05/2022 - 01/2019
3Lung Diseases (Lung Disease)
01/2020 - 11/2016
2Anorexia
04/2022 - 01/2012
2Nausea
04/2022 - 01/2017
2Melanoma (Melanoma, Malignant)
03/2022 - 02/2018
2Pain (Aches)
10/2021 - 11/2015
2Pleurisy (Pleuritis)
09/2019 - 07/2008
2Interstitial Lung Diseases (Interstitial Lung Disease)
05/2018 - 02/2018
2Alzheimer Disease (Alzheimer's Disease)
05/2017 - 08/2012
2Colorectal Neoplasms (Colorectal Cancer)
09/2015 - 01/2012
2Carcinoma (Carcinomatosis)
01/2014 - 05/2004
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
08/2004 - 06/2003
1Pancreatic Neoplasms (Pancreatic Cancer)
05/2022
1Cachexia
04/2022
1Aneuploidy (Aneuploid)
03/2022
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2022
1Communicable Diseases (Infectious Diseases)
03/2022
1Pulmonary Aspergillosis
03/2022
1Aspergillosis
02/2022
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2022
1Hemorrhagic Cystitis
10/2021
1Autoimmune Diseases (Autoimmune Disease)
10/2021
1Inflammation (Inflammations)
10/2021
1Cystitis
10/2021
1Stomach Neoplasms (Stomach Cancer)
08/2021
1Experimental Melanoma
07/2021
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
03/2021

Drug/Important Bio-Agent (IBA)

5DNA (Deoxyribonucleic Acid)IBA
02/2022 - 05/2005
5Pharmaceutical PreparationsIBA
10/2021 - 05/2008
5Prostaglandin-E SynthasesIBA
03/2021 - 12/2009
4Biomarkers (Surrogate Marker)IBA
03/2022 - 01/2019
4Monoclonal AntibodiesIBA
08/2021 - 05/2005
4EnzymesIBA
03/2021 - 05/2008
4prostacyclin synthetase (prostacyclin synthase)IBA
01/2021 - 11/2015
3Cisplatin (Platino)FDA LinkGeneric
04/2022 - 01/2019
3AntigensIBA
07/2021 - 07/2004
3Dinoprostone (PGE2)FDA Link
03/2021 - 12/2009
3MacrolidesIBA
01/2020 - 11/2016
3AntibodiesIBA
01/2020 - 01/2018
3VaccinesIBA
01/2020 - 03/2006
3Rifampin (Rifampicin)FDA LinkGeneric
05/2017 - 07/2008
3GoldIBA
01/2016 - 05/2008
3InterferonsIBA
01/2014 - 08/2004
3Isoniazid (Ftivazide)FDA LinkGeneric
09/2011 - 05/2008
3AcidsIBA
07/2008 - 08/2002
2Small Interfering RNA (siRNA)IBA
05/2022 - 01/2019
2Poly(ADP-ribose) Polymerase InhibitorsIBA
05/2022 - 03/2022
2Proteins (Proteins, Gene)FDA Link
10/2021 - 01/2014
2ProstaglandinsIBA
03/2021 - 09/2015
2Therapeutic UsesIBA
04/2020 - 05/2018
2Immunoglobulin A (IgA)IBA
01/2020 - 09/2019
2Immunoglobulin G (IgG)IBA
01/2019 - 03/2006
2Immunoglobulins (Immunoglobulin)IBA
01/2018 - 03/2006
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
11/2015 - 09/2015
2Tuberculin (PPD)IBA
09/2010 - 07/2004
2PyrazinamideFDA LinkGeneric
07/2008 - 08/2003
2SteroidsIBA
07/2008 - 11/2006
1APOBEC-1 DeaminaseIBA
05/2022
1Cytidine DeaminaseIBA
05/2022
1olaparibIBA
05/2022
1Vinorelbine (Navelbine)FDA LinkGeneric
04/2022
1Antineoplastic Agents (Antineoplastics)IBA
04/2022
1CreatinineIBA
04/2022
1pembrolizumabIBA
04/2022
13-aminobenzamideIBA
03/2022
1HMGB1 Protein (HMG1)IBA
03/2022
1Immunoglobulin E (IgE)IBA
03/2022
1Plasminogen Activator Inhibitor 1IBA
01/2022
1ChromatinIBA
01/2022
1(2-(4-(4-isopropoxybenzyl)-phenylamino) imidazoline)IBA
10/2021
1Epoprostenol (Prostacyclin)FDA LinkGeneric
10/2021
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2021
1ChemokinesIBA
10/2021
1Acrolein (Aqualin)IBA
10/2021
1Protein Isoforms (Isoforms)IBA
08/2021
1Conditioned Culture MediaIBA
07/2021
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
07/2021
1lamellarin 14IBA
05/2021
1anthraceneIBA
03/2021
1pegfilgrastim (Neulasta)FDA Link
03/2021
1amrubicinIBA
03/2021

Therapy/Procedure

13Therapeutics
05/2022 - 07/2008
8Drug Therapy (Chemotherapy)
04/2022 - 07/2005
2Radiotherapy
07/2021 - 01/2011
2Duration of Therapy
01/2020 - 08/2003
2Chemoprevention
09/2015 - 10/2005
2Retreatment
12/2009 - 12/2003
2Gastrectomy
05/2006 - 05/2004
1Adjuvant Chemotherapy
04/2022
1Nuclear Reactors
03/2022
1Boron Neutron Capture Therapy
03/2022
1Immunotherapy
07/2021